Point-of-care testing market projected to reach $48.88 billion by 2030

The point-of-care (POC) testing market is projected to reach $48.88 billion by 2030, driven by a shift from centralized laboratories to bedside, clinic, and home-based diagnostics. The market is expected to grow from $31.46 billion in 2025 to $34.44 billion in 2026, representing a compound annual growth rate (CAGR) of approximately 9.5%.

Key growth drivers include the increasing burden of chronic diseases, the need for rapid clinical decision-making, and advancements in microfluidics, biosensors, and wearable technology. The rise in demand for rapid imaging is also a significant factor. In England, the National Health Service (NHS) reported that imaging examinations reached 47.2 million in the year ending March 2024, a 4.8% increase from the previous year, placing additional pressure on centralized diagnostic facilities.

A major technological trend in this sector is the integration of artificial intelligence into portable devices. For example, Royal Philips recently launched the Compact 5000 series, an AI-powered point-of-care ultrasound system designed to improve image quality and workflow efficiency through automation and remote telemedicine capabilities.